Phase IIa Study Evaluating Safety and Efficacy of BL-8040 in Relapsed/Refractory AML Patients

Clinical trial NCT01838395 · COMPLETED

Trial details

NCT number: NCT01838395
Sponsor: BioLineRx, Ltd.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Acute Myeloid Leukemia

Start date: 2013-04-01
Primary completion: 2016-03-01
Enrollment: 42

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.